H1B Atlas
AB
PERM FY2024-FY2025NAICS 32541

AbbVie Bioresearch Center PERM Filings

Public PERM filing activity, approval signal, filed wage evidence, beneficiary countries, law firms, and role mix for AbbVie Bioresearch Center.

Updated 2026-05-23
View H-1B profile

PERM filings

9records

Approval rate

33.3%FY2024-FY2025

Median filed wage

$83,275base wage

Denied filings

0PERM records

Top country

CHINA1 filings
LCA filings are not visa approvals or open roles — see why this matters
Public filing data is normalized for browsing. LCA filings are not visa approvals or job openings, PERM filings are not individual green-card success rates, and salary figures generally use the lower bound of filed wage ranges and exclude equity, bonus, and benefits. PERM pages describe employer filing activity and should not be read as legal advice or a prediction of an individual case outcome.

PERM filings over time

Annual PERM filing counts across available fiscal years.

FY2024FY2025
FY2024: 2FY2025: 7

Top PERM roles

  • Associate Scientist II3
    $83,275
  • Senior Scientist I2
    $92,602
  • Scientist II1
    $77,210
  • Associate Scientist, Pharmacy II1
    $86,549
  • Senior Scientist I, Systems Immunology1
    $83,000
  • Associate QCA Scientist1
    $82,202

Top beneficiary countries

  • CHINA1
  • ITALY1

Top law firms

  • Hussain Bendersky and Liston LLC7
  • Keith P Liston2

Frequently Asked Questions

How many PERM filings does AbbVie Bioresearch Center have?
AbbVie Bioresearch Center has 9 PERM filings in the available FY2024-FY2025 dataset.
What is the PERM approval rate for AbbVie Bioresearch Center?
The observed PERM approval rate for AbbVie Bioresearch Center is 33.3% based on certified and denied filings in the available dataset.
Which PERM roles appear most often for AbbVie Bioresearch Center?
Common PERM roles for AbbVie Bioresearch Center include Associate Scientist II, Senior Scientist I, Scientist II.
Which beneficiary countries appear most often in AbbVie Bioresearch Center PERM filings?
Common beneficiary countries in AbbVie Bioresearch Center PERM filings include CHINA, ITALY.